Author

T. Shishido

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

T. Hashimoto· 2 shared A. C. Hurt· 1 shared A. Sato· 1 shared B. Clinch· 1 shared E. Mifsud· 1 shared H. Kamada· 1 shared H. Kobayashi· 1 shared H. Konishi· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 15 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

T. Hashimoto

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Discovery of anti-SARS-CoV-2 S2 protein antibody CV804 with broad-spectrum reactivity with various beta coronaviruses and analysis of its pharmacological properties in vitro and in vivo

Y. Tsugawa, K. Furukawa, T. Ise, M. Takayama, T. Ota, T. Kuroda, S. Shano, T. Hashimoto, H. Konishi, T. Ishihara, M. Sato, H. Kamada, K. Fukao, T. Shishido, T. Takahashi, S. Nagata

This study identifies an antibody, CV804, that targets the conserved S2 domain of coronaviruses and shows broad cross-reactivity and ADCC activity against SARS-CoV-2 and related viruses.

bioRxiv · Feb 28, 2024Microbiology

Oral administration of S-217622, a SARS-CoV-2 main protease inhibitor, decreases viral load and accelerates recovery from clinical aspects of COVID-19

M. Sasaki, K. Tabata, M. Kishimoto, Y. Itakura, H. Kobayashi, T. Ariizumi, K. Uemura, S. Toba, S. Kusakabe, Y. Maruyama, S. Iida, N. Nakajima, T. Suzuki, S. Yoshida, H. Nobori, , H. Sawa

This study shows that oral S-217622 reduces SARS-CoV-2 viral load and improves recovery in hamsters, with activity against multiple variants.

bioRxiv · Feb 14, 2022Microbiology

Evaluating the fitness of PA/I38T-substituted influenza A viruses with reduced baloxavir susceptibility in a competitive mixtures ferret model

L. Y. Lee, J. Zhou, P. Koszalka, R. Frise, R. Farrukee, K. Baba, S. Miah, T. Shishido, M. Galiano, T. Hashimoto, S. Omoto, T. Uehara, E. Mifsud, N. Collinson, K. Kuhlbusch, , A. C. Hurt

The paper evaluates the fitness of baloxavir-resistant influenza A viruses in ferrets, finding reduced within-host fitness for A/H3N2 I38T and lower between-host fitness for A/H1N1pdm09 I38T compared to wild-type viruses.

bioRxiv · Sep 28, 2020Microbiology